Navigation Links
Taking dex can improve high altitude exercise capacity in certain climbers
Date:8/11/2009

Taking dexamathasone prophlyactically may improve exercise capacity in some mountaineers, according to Swiss researchers. Dexamathasone, known popularly to climbers as "dex," has been used for years to treat altitude-related symptoms in mountaineers, but has never been tested for its ability to improve exercise capacity at high altitude.

"We have known that both tadalafil and dexamethasone are good for preventing high altitude pulmonary edema (HAPE) and dex for treating symptoms of acute mountain sickness (AMS). But we did not know whether they could also improve exercise capacity at altitude by reducing pulmonary hypertension, one of the important factors in altitude- related exercise limitations," said lead authors Manuel Fischler, MD, of the University Hospital in Zurich, Switzerland, and Hans-Peter Brunner-La Rocca, of the University Hospital in Basel, Switzerland.

The results were published in the August 15th issue of the American Journal of Respiratory and Critical Care Medicine, the journal of the American Thoracic Society.

The researchers recruited 23 mountaineers with a history of HAPE and administered baseline cardiopulmonary exercise tests a low elevation (490 meters, or 1607 feet). Subjects were tested for oxygen uptake kinetics by pedaling a stationary bike at a constant rate for six minutes, and then for exercise capacity by pedaling at 50 percent of their predicted maximum workload for one minute, then increasing output by 25 percent each additional minute until exhaustion, usually after 8 to 12 minutes.

"At low altitude, peak exercise performance of subjects was significantly above age- and gender-adjusted normal values, indicating superior fitness in these subjects," noted Dr. Fischler.

All participants were randomized to take either tadalifil, dexamethasone or placebo, beginning the day before a cable-car ascent from Alagna, Italy, at 1,100 meters (3,609 feet), to 3,200 meters (10,499 feet). They then ascended on foot to Capanna Gnifetti at 3,650 meters (11,975 feet). After an overnight stay at Capanna Gnifetti, the climbers finally ascended to Capanna Regina Margherita at 4,559 meters (14,957 feet).

A second round of cardiopulmonary exercise tests were performed 4-5 hours after arrival, and echocardiographic examinations were performed the next day.

"Reduced oxygen content in the air is the major limiting factor at high altitude. Reduction in exercise capacity goes in parallel to the reduction in oxygen up to an altitude of approximately 4000 meters. At higher altitudes, there is an even further reduction in exercise capacity," said Dr. Fischler. "As expected, exercise capacity at high altitudes was diminished among all groups and key indictors of cardiopulmonary stress were elevated."

Both tadalafil and dexamethasone subjects showed a smaller drop in oxygen saturation over the placebo group, indicating a better uptake of oxygen, and a measure of pulmonary artery pressure was significantly less for both tadalifil and dexamethasone groups over placebo.

But dexamethasone did show certain advantages over tadalafil. Heart rate increased in all groups, but significantly less so in the dexamethasone group, suggesting less activation of the autonomous nervous system at high altitude. While AMS did not differ between groups on day one, it was significantly less among the dexamethasone group on day two. Finally, and perhaps most significantly, VO2max (a key measurement of how efficiently the body is able to use oxygen) was significantly higher in the dexamethasone group at high altitude compared to both placebo and tadalafil groups.

"In this study, we found that the most important limiting factor [with respect to exercise capacity at high altitude] is primarily pulmonary hypertension elevated blood pressure in the circulation of the lungs which may further reduce the oxygen uptake, particularly during exercise. Our study indicates that for HAPE-susceptible climbers, taking dexamethasone improved exercise capacity, oxygen uptake kinetics and decreased the anaerobic threshold," said Dr. Fischler. "Overall, this means that those climbers who took dex felt better, were able to do more, and probably experienced fewer altitude-related discomforts than both other groups."

Glucocorticosteroids such as dexamethasone probably increase exercise capacity through several different mechanisms. They lower pulmonary artery pressure by enhancing nitric oxide availability, as well as stimulating alveolar sodium and water clearance, which may improve oxygen diffusion. Furthermore, they have anti-inflammatory properties and may act on the mental state of those who take it, endowing them with increased willingness to exert themselves.

"There is, however, a word of caution to be made regarding the use of glucocorticosteriods," said Dr. Fischler. "Although short-term tolerability is generally good, they have significant side effects. They reduce the inflammatory response to infections, the increase blood glucose and in the long term, they may lead to osteoporosis, reduce muscle mass and skin thickness, just to name the most important ones. Therefore, they should not be used without prescription by a medical doctor. Further studies need to be done to determine whether these results are generalizeable to non-HAPE-susceptible climbers, but our research strongly suggests that dex taken prophylactically can have a therapeutic effect in those who have experience HAPE in the past."


'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.com
212-315-8620
American Thoracic Society
Source:Eurekalert

Related medicine news :

1. Depression Taking Toll on Returning U.S. Vets
2. 13 percent of women stop taking breast cancer drug because of side effects, U-M study finds
3. Study finds drug spending caps cause some seniors to quit taking key medicines
4. The Nutrition-Conscious Are Taking a Bite Out of Fast Food
5. New Resource for Taking Care of Aging Parents Available in Beta
6. Study finds drug spending caps cause some seniors to quit taking key medicines
7. Blue Cross And Blue Shield Association Survey Shows Consumer Driven Health Plan Enrollees Are Taking More Control of Their Healthcare
8. Taking the stress out of choosing the right stress test
9. Better Prostate Cancer Survival for Men Taking Statins
10. Multi-talented Entertainer Chris Brown Goes Back to School, Taking on a Starring Role in the St. Jude Math-A-Thon (R) Video
11. Mayo Clinic study finds that after heart attack most patients stop taking life-saving drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has ... the Atlanta Football Host Committee (AFHC) for the 2018 College ... Jan. 8, 2018, at Mercedes-Benz Stadium in Atlanta, ... of the AFHC "I,m In" campaign, participating in many activities ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology: